Defining FERMT2 as a regulator of tumour cell state plasticity and metastatic stress adaptation in prostate cancer
School of Medicine, Dentistry and Biomedical Sciences
- Location
- Belfast, United Kingdom
- Funding
- See university guidance
- Application deadline
- See university guidance
About the project
My research focuses on cancer genomics and bioinformatics, investigating how non-coding mutations drive cancer progression. I integrate GWAS, epigenetics, and tumour sequencing to identify regulatory elements influencing disease risk. In colorectal cancer and AML, I study cryptic transcription and translation to understand how tumour-specific antigens arise and are regulated. Functional genomics experiments are used to explore the mechanisms underpinning these processes and their translational potential.
- Dr Sarah Maguire: School of Medicine, Dentistry and Biomedical Sciences
Contact info
- View Academic Profile
- s.maguire@qub.ac.uk
- 02890972940
Research Interests
Open to PhD applications in the fields of:
Make a PhD enquiry
- Cancer genomics
- Bioinformatics
- Single-cell omics
- Translational oncology
Current Research Opportunities
- Defining FERMT2 as a regulator of tumour cell state plasticity and metastatic stress adaptation in prostate cancer
Public outreach & key achievements
- Academic Lead for Bioinformatics at the Future Medicines Institute and the QUB Genomics and Cytometry Core.
- Actively engaged in public engagement on cancer genomics, including media appearances and school outreach.
Discover More
- Faculty of Medicine, Health and Life Sciences
- School of Medicine, Dentistry and Biomedical Sciences